PVG Asset Management’s BioAtla BCAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,380
Closed -$39.2K 128
2025
Q4
$39.2K Buy
1,380
+40
+3% +$1.57K 0.08% 89
2025
Q3
$46.1K Buy
1,340
+40
+3% +$923 0.17% 66
2025
Q2
$25.7K Hold
1,300
0.09% 57
2025
Q1
$22.5K Buy
1,300
+580
+81% +$12.4K 0.1% 44
2024
Q4
$21.3K Buy
+720
New +$60.4K 0.1% 44
2023
Q4
$161K Buy
+1,307
New +$113K 0.78% 28

Other funds holding BCAB

PVG Asset Management's BCAB Position: Q1 2026 in Review

PVG Asset Management sold out of BioAtla (BCAB) in Q1 2026, closing a stake of 1,380 shares — an estimated $39.2K sold.

PVG Asset Management first reported a position in BCAB in Q4 2023 and held it in 6 quarters. The position peaked at $161K in Q4 2023. 36 funds tracked by Wall St. Rank hold BCAB as of Q1 2026.

  • PVG Asset Management reported no remaining BioAtla position as of Q1 2026 after selling out during the quarter.
  • PVG Asset Management sold 1,380 BioAtla shares in Q1 2026, an estimated $39.2K.
  • PVG Asset Management first reported a position in BioAtla in Q4 2023 and held it in 6 quarters.
  • PVG Asset Management's BioAtla position peaked at $161K in Q4 2023.
  • 36 funds tracked by Wall St. Rank held BioAtla as of Q1 2026.

Based on PVG Asset Management's 13F filing for Q1 2026, filed 16 Jun 2026.